Clinical Trial Update: A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial update for VTX-801 in adults with Wilson's disease, with results posted January 28, 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• VTX-801

Snippet

Sponsor: Vivet Therapeutics SAS | Conditions: Wilson's Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-28